364 related articles for article (PubMed ID: 17449759)
21. Treatment options for unresectable neuroendocrine liver metastases.
John BJ; Davidson BR
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
[TBL] [Abstract][Full Text] [Related]
22. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience.
Gonsalves CF; Eschelman DJ; Sullivan KL; Anne PR; Doyle L; Sato T
AJR Am J Roentgenol; 2011 Feb; 196(2):468-73. PubMed ID: 21257902
[TBL] [Abstract][Full Text] [Related]
23. Embolization and chemoembolization therapy for neuroendocrine tumors.
Venook AP
Curr Opin Oncol; 1999 Jan; 11(1):38-41. PubMed ID: 9914876
[TBL] [Abstract][Full Text] [Related]
24. Hepatic neuroendocrine metastases: does intervention alter outcomes?
Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
[TBL] [Abstract][Full Text] [Related]
25. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
26. Hepatic arterial chemoembolization for metastatic endocrine tumors.
Stokes KR; Stuart K; Clouse ME
J Vasc Interv Radiol; 1993; 4(3):341-5. PubMed ID: 8390317
[TBL] [Abstract][Full Text] [Related]
27. Hepatic arterial chemoembolization for management of metastatic melanoma.
Sharma KV; Gould JE; Harbour JW; Linette GP; Pilgram TK; Dayani PN; Brown DB
AJR Am J Roentgenol; 2008 Jan; 190(1):99-104. PubMed ID: 18094299
[TBL] [Abstract][Full Text] [Related]
28. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
[TBL] [Abstract][Full Text] [Related]
29. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
[TBL] [Abstract][Full Text] [Related]
30. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
Landry CS; Scoggins CR; McMasters KM; Martin RC
J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
[TBL] [Abstract][Full Text] [Related]
31. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Perry LJ; Stuart K; Stokes KR; Clouse ME
Surgery; 1994 Dec; 116(6):1111-6; discussion 1116-7. PubMed ID: 7985095
[TBL] [Abstract][Full Text] [Related]
32. Hepatic artery embolization for treatment of endocrine gastrointestinal tumors with liver metastases.
Stöckmann F; Von Romatowski HJ; Reimold WV; Schuster R; Creutzfeldt W
Z Gastroenterol; 1984 Nov; 22(11):652-60. PubMed ID: 6097061
[TBL] [Abstract][Full Text] [Related]
33. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
Strosberg JR; Choi J; Cantor AB; Kvols LK
Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
[TBL] [Abstract][Full Text] [Related]
34. Hepatic neuroendocrine metastases: chemo- or bland embolization?
Pitt SC; Knuth J; Keily JM; McDermott JC; Weber SM; Chen H; Rilling WS; Quebbeman EJ; Agarwal DM; Pitt HA
J Gastrointest Surg; 2008 Nov; 12(11):1951-60. PubMed ID: 18709512
[TBL] [Abstract][Full Text] [Related]
35. Repeated hepatic arterial chemoembolization therapy for management of a patient with metastatic carcinoid tumors of the liver.
Nakaoka R; Kamisako T; Shiomi M; Kudo M
Am J Gastroenterol; 2000 Jul; 95(7):1842-3. PubMed ID: 10926003
[No Abstract] [Full Text] [Related]
36. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic alternatives in metastatic neuroendocrine tumors.
Miller CA; Ellison EC
Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
[TBL] [Abstract][Full Text] [Related]
38. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
Nakakura EK; Venook AP; Bergsland EK
Surg Oncol Clin N Am; 2007 Jul; 16(3):639-51, x. PubMed ID: 17606198
[TBL] [Abstract][Full Text] [Related]
39. Chemoembolization in liver malignant involvement. Experiences on 17 cases.
Fiorentini G; Campanini A; Dazzi C; Davitti B; Graziani G; Priori T; Ricci Bitti R; Angelini L
Minerva Chir; 1994 Apr; 49(4):281-5. PubMed ID: 8072703
[TBL] [Abstract][Full Text] [Related]
40. Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse E; Breittmayer F; Roche A; De Baere T; Indushekar S; Ducreux M; Lasser P; Elias D; Rougier P
Radiology; 1993 Nov; 189(2):541-7. PubMed ID: 7692465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]